EUVIMEDEUVIMED entdecken
Crossref

Personalized brain stimulation gains FDA clearance for PTSD

Claudine McCarthy

Mental Health Weekly · 09.11.2026 · 36 (43) · 5-6

DOI: 10.1002/mhw.35070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mental Health Weekly, online erschienen am 06.11.2026. Verfasst von Claudine McCarthy.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Federal regulators have cleared a personalized treatment for post‐traumatic stress disorder (PTSD) that combines brain mapping with magnetic stimulation to guide care. Researchers say the approach could help expand options for individuals who do not respond adequately to existing therapies and may have implications for treating other mental health conditions.

Zitieren

APA

McCarthy, C. (2026). Personalized brain stimulation gains FDA clearance for PTSD. Mental Health Weekly, 36(43), 5-6. https://doi.org/10.1002/mhw.35070

Vancouver

McCarthy C. Personalized brain stimulation gains FDA clearance for PTSD. Mental Health Weekly. 2026;36(43):5-6. doi:10.1002/mhw.35070

BibTeX
@article{McCarthy2026,
  author = {McCarthy, Claudine},
  title = {Personalized brain stimulation gains FDA clearance for PTSD},
  journal = {Mental Health Weekly},
  year = {2026},
  volume = {36},
  number = {43},
  pages = {5--6},
  doi = {10.1002/mhw.35070}
}
Kostenlos starten →